Tuesday, 27 June 2017

Detailed Study of the Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Leukemia Diagnostic Tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Leukemia Diagnostic Tests pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.
- Extensive coverage of the Leukemia Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Leukemia Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Leukemia Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
Acobiom Aegis Sciences Corp BioSense Technologies, Inc. Cancer Genetics Inc Cell2in CeMines, Inc. Cepheid Di.V.A.L Toscana srl DiaSorin S.p.A Eutropics Pharmaceuticals Inc H. Lee Moffitt Cancer Center & Research Institute Inc Health Discovery Corp IV Diagnostics, Inc. Jaden BioScience Inc. King's College London Microfluidic Innovations LLC Monoquant Pty. Ltd. Nodality Inc NuCana BioMed Ltd Nuclea Biotechnologies Inc. OncoVista Innovative Therapies Inc Roche Diagnostics International Ltd Siemens Healthcare GmbH SkylineDx BV St. Jude Children’s Research Hospital Inc Stanford University The Feinstein Institute for Medical Research Treos Bio Inc University of Bergen University of California San Diego University of Colorado University of Missouri University of Pennsylvania Vela Diagnostics Pte. Ltd Vivia Biotech SL Wake Forest Baptist Medical Center
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research

No comments:

Post a Comment